Sex differences in the efficacy of omalizumab in the treatment of chronic spontaneous urticaria
Background Omalizumab is shown to be effective in the treatment of chronic spontaneous urticaria (CSU), a disease with high personal and social impact. Sex differences in CSU are recognized with women more frequently affected. Scarce is the knowledge about response to omalizumab between sex groups....
محفوظ في:
| المؤلفون الرئيسيون: | , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
SAGE Publishing
2021-12-01
|
| سلاسل: | International Journal of Immunopathology and Pharmacology |
| الوصول للمادة أونلاين: | https://doi.org/10.1177/20587384211065870 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|